Evaluation of the BD phoenix automated identification and susceptibility testing system in clinical microbiology laboratory practice

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 22, Issue 8, 2003, Pages 479-485

  Stefaniuk, E ^a   Baraniak, A ^a   Gniadkowski, M ^a   Hryniewicz, W ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; TETRACYCLINE; VANCOMYCIN;

ACCURACY; ANALYTIC METHOD; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOMATION; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DILUTION; ENTEROBACTERIACEAE; ENTEROCOCCUS; EVALUATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INTERMETHOD COMPARISON; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUALITY CONTROL; STAPHYLOCOCCUS;

ANTI-BACTERIAL AGENTS; AUTOMATION; BACTERIOLOGICAL TECHNIQUES; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MICROBIAL SENSITIVITY TESTS; SENSITIVITY AND SPECIFICITY;

EID: 0041909726     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-003-0962-y     Document Type: Article

References (16)

1. Facklam R, Collins MD (1989) Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 27:731-734
2. National Committee for Clinical Laboratory Standards (2000) Methods for dilution susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5. NCCLS, Villanova, PA
3. National Committee for Clinical Laboratory Standards (2002) Performance standards for antimicrobial susceptibility testing. Informational supplement M100-S12. NCCLS, Villanova, PA
4. National Committee for Clinical Laboratory Standards (2000) Performance standards for antimicrobial disk susceptibility testing. Approved standard M2-A7. NCCLS, Villanova, PA
5. Murakami K, Minimide W, Wada K, Nakamura E, Teraoka H, Watanabe S (1991) Identification of methicillin-resistant strains of Staphylococcus aureus by polymerase chain reaction. J Clin Microbiol 29:2240-2244
6. Dutka-Malen S, Evers S, Courvalin P (1995) Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 33:24-27
7. Dahl KH, Skov Simonsen G, Olsvik R, Sundsfjord A (1999) Heterogeneity in vanB gene cluster of genetically diverse clinical strains of vancomycin-resistant enterococci. Antimicrob Agents Chemother 43:1105-1110
8. Jarlier V, Nicolas JE, Fournier G, Philippon A (1988) Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10:2141-2143
9. Pałucha A, Mikiewicz B, Hryniewicz W, Gniadkowski M (1999) Concurrent outbreaks of extended-spectrum beta-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital. J Antimicrob Chemother 44:489-499
10. Fiett J, Pałucha A, Mia̧czyńska B, Stankiewicz M, Przondo-Mordarska H, Hryniewicz W, Giadkowski M (2000) A novel complex mutant beta-lactamase, TEM-68, identified in a Klebsiella pneumoniae isolate from an outbreak of extended-spectrum beta-lactamase-producing klebsiellae. Antimicrob Agents Chemother 44:1499-1505
11. Gniadkowski M, Schneider I, Patucha A, Jungewirth R, Mikiewicz B, Bauernfeind A (1998) Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob Agents Chemother 42:827-832
12. Baraniak A, Fiett J, Sulikowska A, Hryniewicz W, Gniadkowski M (2002) Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland. Antimicrob Agents Chemother 46:151-159
13. Livermore DM (1995) β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8:557-584
14. Brisse S, Stefani S, Verhoef J, Van Belkum A, Vandamme P, Goessens W (2002) Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex. J Clin Microbiol 40:1743-1748
15. Endimiani A, Luzzaro F, Tamborini A, Lombardi G, Elia V, Belloni R, Toniolo A (2002) Identification and antimicrobial susceptibility testing of clinical isolates of nonfermenting gram-negative bacteria by the Phoenix Automated Microbiology System. New Microbiol 25:323-329
16. Leverstein-van Hall MA, Fluit AC, Paauw A, Box ATA, Brisse S, Verhoef J (2002) Evaluation of the E test ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum β-lactamases in multiresistant Escherichia coli and Klebsiella spp. J Clin Microbiol 40:3703-3711